← Leaderboards
David L Waning
Indiana University Indianapolis
$371,816
Attributed
$371,816
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $203.6K · FY2016–17$250K$187.5K$125K$62.5K$0
'16
'17
Funding mix
By agency
NIH$371,816 · 1
By mechanism
R21$371,816 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Paul Richard Territo$22,416,914
- Thomas D. Hurley$11,294,425
- Wei Wu$1,558,709
- Jill C Fehrenbacher$3,349,946
- Melissa A Kacena$7,991,370
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAnimal ModelAntioxidantsAffectBiochemicalBoneBone MatrixBone ResorptionBindingBreast Cancer TreatmentCalciumCancer ModelCancer PatientCancer TherapyCarboplatinChemotherapeutic AgentChemotherapyCombination Drug TherapyCouplingDiagnosisDisease RemissionDoxorubicinEffective TherapyFeeding
Grant awards (3)
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle$168,236
R21 · FY2017 · CA · contact PI
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle$152,333
R21 · FY2016 · CA · contact PI
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle.$51,247
R21 · FY2016 · CA · contact PI